Latest News
Featured News
Preliminary Results for the Year Ended 30 April 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded
First patient dosed in Modi-1 Phase 1 clinical trial
Modi-1 Phase 1/2 clinical trial open for recruitment
Broadening of COVIDITY Phase 1 clinical trial in South Africa
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.